Tower Research Capital (TRC)’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-508
| Closed | -$10.8K | – | 6126 |
|
|
2024
Q1 | $10.8K | Sell |
508
-2,500
| -83% | -$53.3K | ﹤0.01% | 3641 |
|
|
2023
Q4 | $28.9K | Buy |
3,008
+2,869
| +2,064% | +$27.6K | ﹤0.01% | 3445 |
|
|
2023
Q3 | $361 | Buy |
+139
| New | +$361 | ﹤0.01% | 5590 |
|
|
2022
Q3 | – | Sell |
-3,259
| Closed | -$8K | – | 6637 |
|
|
2022
Q2 | $8K | Buy |
+3,259
| New | +$8K | ﹤0.01% | 4725 |
|
|
2022
Q1 | – | Sell |
-1,160
| Closed | -$5K | – | 6725 |
|
|
2021
Q4 | $5K | Sell |
1,160
-1,494
| -56% | -$6.44K | ﹤0.01% | 5217 |
|
|
2021
Q3 | $21K | Sell |
2,654
-361
| -12% | -$2.86K | ﹤0.01% | 3684 |
|
|
2021
Q2 | $24K | Buy |
3,015
+1,457
| +94% | +$11.6K | ﹤0.01% | 3744 |
|
|
2021
Q1 | $17K | Buy |
+1,558
| New | +$17K | ﹤0.01% | 4023 |
|